Insider filing · ROIV
Rakhi Kumar
Chief Accounting Officer
profile →
Roivant Sciences Ltd.
ROIV · Healthcare · 74 filings in 24 months
ticker →
Rakhi Kumar sold $2.4M of Roivant Sciences (ROIV)
Executed Feb 13 2025, disclosed Feb 18 2025, 5 days later.
Value, as filed
$2.4M
227,500 sh × $10.43
Executed
Feb 13 2025
the trade date, as filed
Disclosed
Feb 18 2025
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RKRakhi Kumar (Chief Accounting Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $2.4M of ROIV (227,500 sh × $10.43, as filed), executed Feb 13 2025.
The name
ROIVHealthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→